These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7520660)

  • 1. Pharmacological background to decongesting and anti-inflammatory treatment of rhinitis and sinusitis.
    Malm L
    Acta Otolaryngol Suppl; 1994; 515():53-5; discussion 55-6. PubMed ID: 7520660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stringan: decongestant and nasal anti-inflammatory agent].
    Truffer E
    Rev Med Suisse Romande; 1968 Jun; 88(6):419-26. PubMed ID: 4190158
    [No Abstract]   [Full Text] [Related]  

  • 3. Belgian guidelines for the treatment of acute rhinosinusitis in general practice.
    Bachert C; Bertrand B; Daele J; Jorissen M; Lefèbvre R; Rombaux P; Schmelzer B
    B-ENT; 2007; 3(4):175-7. PubMed ID: 18265721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with the vasoconstrictor action of H 1032 on the nasal mucosa].
    Carta F
    Arch Ital Otol Rinol Laringol Patol Cervicofacc; 1967; 78(4):510-9. PubMed ID: 4180004
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of nasal decongestants on locomotor activity of the ciliary apparatus of nasal mucosa in patients with acute purulent rhinosinusitis].
    Kramnoĭ AI; Kozlov VS
    Vestn Otorinolaringol; 2010; (1):67-8. PubMed ID: 20436429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha-mimetic effects on nasal mucosa in magnetic resonance tomography].
    Benammar-Englmaier M; Hallermeier JK; Englmaier B
    Digitale Bilddiagn; 1990 Jun; 10(2):46-50. PubMed ID: 1698586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of acute nonspecific rhinitis. Studies on the long-term effect of Cimporhin].
    Hinkelmann B
    Fortschr Med; 1972 Sep; 90(26):957-8. PubMed ID: 4118117
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis].
    Klossek JM
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(3):187-92. PubMed ID: 18323331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The management of restricted nasal respiration using nasal decongestants. Purposeful and senseless use].
    Rüdiger W
    Med Klin; 1963 Sep; 58(36):1489-91 passim. PubMed ID: 4174555
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug treatment of sinusitis].
    Van Cauwenberge P
    Acta Otorhinolaryngol Belg; 1983; 37(4):614-23. PubMed ID: 6196935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience in the use of a nose drop, Otrivin].
    Mizukoshi O; Sasaki H; Imamura C; Kawamoto A; Hama H
    Jibiinkoka; 1967 Sep; 39(9):1021-114. PubMed ID: 4170718
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of the preparation "Betadrin-Polfa"].
    Klonowski S; Semczuk B; Pomykalski M; Czerwonka R
    Pol Tyg Lek; 1969 Feb; 24(6):209-11. PubMed ID: 4180773
    [No Abstract]   [Full Text] [Related]  

  • 13. [Corticosteroid is efficient against abuse of nasal decongestants].
    Graf P; Enerdal J; Hallén H
    Lakartidningen; 1998 Sep; 95(40):4344-6. PubMed ID: 9800453
    [No Abstract]   [Full Text] [Related]  

  • 14. What you need to know--medications for rhinitis--uses and abuses.
    Soh KB
    Singapore Med J; 1999 Feb; 40(2):120-2. PubMed ID: 10414175
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intranasal steroid therapy in inflammatory nasal-sinus pathology in pediatric age].
    Berlucchi M; Tomenzoli D
    Minerva Pediatr; 2009 Jun; 61(3):323-31. PubMed ID: 19461575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment results with dioxopromethazine nose drops].
    Knothe J; Baerthold W; Aschoff E
    Pharmazie; 1970 Feb; 25(2):121-4. PubMed ID: 4192880
    [No Abstract]   [Full Text] [Related]  

  • 17. [Steroid sprays in non-infectious rhinitis and sinusitis. Proper and regular spraying does not damage the nasal mucosa].
    Klimek L; Bachert C; Hörmann K
    MMW Fortschr Med; 2002 Mar; 144(10):41-3. PubMed ID: 11928263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally administered decongestant drugs in disorders of the upper respiratory passages: a survey of clinical results.
    Anggård A; Malm L
    Clin Otolaryngol Allied Sci; 1984 Feb; 9(1):43-9. PubMed ID: 6202443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sinonasal disease and nasal saline.
    Acar B; Karabulut H
    Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):625; author reply 625. PubMed ID: 17576921
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inflammatory pathologies of the rhinosinusitis: rationale for the use of anti-inflammatory agents].
    Bellussi L
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):21-5, 37-40. PubMed ID: 15058606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.